Clinicians and scientists are sounding alarms as the Trump administration slashes budgets at federal health agencies, including the NIH, which is the largest funder of cancer research in the world. We talk about the costs of the cuts, which researchers say could set back progress on treatments and cures by decades and jeopardize patients with advanced forms of cancer who rely on experimental clinical trials.
Federal Funding Cuts Hit Cancer Research
We talk about the costs of cuts to cancer research, which researchers say could set back progress on treatments and cures by decades and jeopardize patients.
(wildpixel via iStock)
Guests:
Angus Chen, cancer reporter, STAT News
Dr. Adil Daud, oncologist and melanoma specialist, UCSF